Coeptis Therapeutics (COEP) Institutional Ownership $0.19 0.00 (-0.15%) (As of 04:28 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Coeptis Therapeutics (NASDAQ:COEP)CurrentInstitutional OwnershipPercentage13.88%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.03MNumber ofInstitutional Sellers(last 12 months)0 Get COEP Insider Trade Alerts Want to know when executives and insiders are buying or selling Coeptis Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data COEP Institutional Buying and Selling by Quarter Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! Coeptis Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024 Armistice Capital LLC3,520,000$2.76M0.0%+59.1%10.320% 11/15/2023 Armistice Capital LLC2,212,000$2.57M0.0%-5.1%8.799% 8/15/2023 Ionic Capital Management LLC45,000$70K0.0%N/A0.209% 7/21/2023 Creative Planning645,103$1M0.0%N/A2.995% 5/12/2023 Antara Capital LP45,000$64K0.0%N/A0.220% 2/14/2023 Susquehanna International Group LLP16,341$25K0.0%N/A0.319% 2/10/2023 Creative Planning645,103$988K0.0%N/A12.600% 2/10/2023 HRT Financial LP172,635$267K0.0%N/A3.372% 2/8/2023 Cambridge Investment Research Advisors Inc.31,670$48K0.0%N/A0.619% 2/6/2023West Chester Capital Advisors Inc.2,863,382$4.39M8.7%N/A55.925% (Data available from 1/1/2016 forward) COEP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of COEP shares? During the previous two years, the following institutional investors and hedge funds held shares of Coeptis Therapeutics shares: West Chester Capital Advisors Inc. ($4.39M), Armistice Capital LLC ($2.76M), Creative Planning ($1M), HRT Financial LP ($267K), Ionic Capital Management LLC ($70K), Antara Capital LP ($64K), and Cambridge Investment Research Advisors Inc. ($48K).Learn more on COEP's institutional investors. What percentage of Coeptis Therapeutics stock is owned by institutional investors? 13.88% of Coeptis Therapeutics stock is owned by institutional investors. Learn more on COEP's institutional investor holdings. Which institutional investors have been buying Coeptis Therapeutics stock? The following institutional investors have purchased Coeptis Therapeutics stock in the last 24 months: West Chester Capital Advisors Inc. ($2.86M), Armistice Capital LLC ($1.31M), Creative Planning ($1.29M), HRT Financial LP ($172.64K), Ionic Capital Management LLC ($45K), Antara Capital LP ($45K), and Cambridge Investment Research Advisors Inc. ($31.67K). How much institutional buying is happening at Coeptis Therapeutics? Institutional investors have bought a total of 5,772,234 shares in the last 24 months. This purchase volume represents approximately $7.87M in transactions. Which Coeptis Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Coeptis Therapeutics stock in the last 24 months: Armistice Capital LLC ($119K). How much institutional selling is happening at Coeptis Therapeutics? Institutional investors have sold a total of 119,000 shares in the last 24 months. This volume of shares sold represents approximately $138.04K in transactions. Related Companies Ensysce Biosciences Major Shareholders Passage Bio Major Shareholders Lantern Pharma Major Shareholders Acasti Pharma Major Shareholders BioVie Major Shareholders ProMIS Neurosciences Major Shareholders LianBio Major Shareholders Citius Pharmaceuticals Major Shareholders KALA BIO Major Shareholders Surrozen Major Shareholders This page (NASDAQ:COEP) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best n...Resource Stock Digest | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coeptis Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
